pteridines has been researched along with Demyelinating Diseases in 1 studies
Demyelinating Diseases: Diseases characterized by loss or dysfunction of myelin in the central or peripheral nervous system.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Volasertib is a potent inhibitor of Polo-like kinase (PLK) 1 and to lesser extent also PLK2 and PLK3." | 2.50 | Volasertib for the treatment of acute myeloid leukemia: a review of preclinical and clinical development. ( Fiedler, W; Janning, M, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Janning, M | 1 |
| Fiedler, W | 1 |
1 review available for pteridines and Demyelinating Diseases
| Article | Year |
|---|---|
Volasertib for the treatment of acute myeloid leukemia: a review of preclinical and clinical development.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Demyelinating Diseases; Disease | 2014 |